Safety and Effectiveness of Ciclesonide Nasal Spray in Patients With Perennial Allergic Rhinitis During One Year Treatment (BY9010/M1-404)
Phase 3
Completed
- Conditions
- Hay FeverPerennial Allergic RhinitisAllergic Rhinitis
- Registration Number
- NCT00163501
- Lead Sponsor
- AstraZeneca
- Brief Summary
The purpose of this study is to investigate the safety and effectiveness of ciclesonide nasal spray as compared with placebo (inactive substance) nasal spray in relieving symptoms of perennial allergic rhinitis.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 600
Inclusion Criteria
- General good health, other than perennial allergic rhinitis
- History and diagnosis of perennial allergic rhinitis by skin prick test
Main
Exclusion Criteria
- Participation in any investigational drug trial within the 30 days preceding the Screening Visit
- A known hypersensitivity to any corticosteroid or any of the excipients in the formulation
- Use of any prohibited concomitant medications as defined by the study protocol
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method change in Total Nasal Symptom Scores.
- Secondary Outcome Measures
Name Time Method change in symptoms, quality of life, safety.
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What are the molecular mechanisms of ciclesonide in treating perennial allergic rhinitis?
How does ciclesonide nasal spray compare to other corticosteroids in PAR treatment effectiveness?
What biomarkers predict response to ciclesonide in patients with perennial allergic rhinitis?
What are the long-term adverse events associated with ciclesonide nasal spray in PAR patients?
Are there combination therapies involving ciclesonide for enhanced allergic rhinitis treatment outcomes?
Trial Locations
- Locations (1)
Altana Pharma/Nycomed
🇺🇸Milwaukee, Wisconsin, United States
Altana Pharma/Nycomed🇺🇸Milwaukee, Wisconsin, United States